The COVID-19 pandemic highlighted an urgent need for efficient, durable, and widely accessible vaccines. This prompted several important innovations in vaccine technology, and researchers continue to ...
A Phase I/II randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
CORK, Ireland, Feb. 10, 2026 /PRNewswire/ -- ArrayPatch Ltd, a biotech company developing innovative microneedle-based therapeutics, today announced the first close of its €3 million seed funding ...
Researchers have used 3D-printing technology to improve the viral titer of microneedle array patches, resulting in effective immunogenicity and protection against infection in mice. (Nanowerk News) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results